Onkológia 2/2026
Zaujímavosti zo zahraničnej literatúry
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).
Enter your login e-mail to the account
Chcete mať vždy aktuálne informácie o tom, čo pre vás pripravujeme?
Prihláste sa na odoberanie noviniek a budete ich dostávať na vašu e-mailovú adresu.
The information contained on these pages is intended only for medical professionals and serves the needs of medical education
© 2023 Solen s.r.o. All rights reserved. Copying any part of this page without the permission of the author is prohibited.